Charme Capital Partners and EQT Private Equity to sell Igenomix to Vitrolife
Charme has announced that Charme III, its €650m buyout fund and EQT have reached an agreement with Vitrolifeto sell Igenomix. As part of the transaction Igenomix’s shareholders will retain a minority shareholder stake in Vitrolife.